Altamira Therapeutics Ltd
NASDAQ:CYTO

Watchlist Manager
Altamira Therapeutics Ltd Logo
Altamira Therapeutics Ltd
NASDAQ:CYTO
Watchlist
Price: 0.1198 USD -60.07% Market Closed
Market Cap: 300k USD

Bankruptcy Probability

Altamira Therapeutics Ltd's probability of bankruptcy is hidden . The solvency score is hidden .

We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.

Bankruptcy Probability
HIDDEN
Show

Financial Position

A solvent company is one that owns more than it owes. Comparing the amount of cash and investments with existing debt gives an idea of the company's long-term financial health.

Show More Less
Cash & ST Investments
+
3Y
-99%
5Y
-99%
10Y
-99%
Long-Term Investments
+
3Y
-
5Y
-
10Y
-
Debt
+
3Y
-
5Y
-
10Y
-

Interest Coverage

To determine how easily a company can pay interest on its outstanding debt, the Interest Coverage ratio is used. It represents how many times the company can pay its obligations using its operating income.

The lower the ratio, the more the company is burdened by debt expenses. When a company's interest coverage ratio is only 1.5 or lower, its ability to meet interest expenses may be questionable.

Show More Less

All Solvency Ratios

Other solvency & liquidity ratios which help to assess the company’s capacity to stay afloat.

Is Altamira Therapeutics Ltd at risk of bankruptcy?

Altamira Therapeutics Ltd's probability of bankruptcy is hidden .

The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Altamira Therapeutics Ltd have?

As of the latest report, Altamira Therapeutics Ltd has total debt of 304.1k CHF. This includes both short-term (0 CHF) and long-term (304.1k CHF) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top